{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/creating-patient-and-site-centric-solutions-challenging-antibiotic-study#webpage",
"url": "https://www.fortrea.com/insights/creating-patient-and-site-centric-solutions-challenging-antibiotic-study",
"name": "Creating patient- and site-centric solutions for a challenging antibiotic study",
"description": "Explore how this case study highlights the challenges in antibiotic clinical trials, including antibiotic resistance in emerging infectious diseases and barriers in global clinical development. Learn how patient- and site-centric strategies improve infectious disease patient recruitment, strengthen site engagement, and support more efficient trial execution. Explore how antibiotic clinical trial design must adapt to address evolving resistance patterns, operational complexity, and funding challenges in antibiotic development. Learn how site-focused collaboration and patient-centric approaches enhance study feasibility and outcomes in complex infectious disease trials. By integrating scientific innovation with patient- and site-centric execution, this case study demonstrates how antibiotic clinical trials can evolve to overcome challenges and advance infectious disease drug development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Creating patient- and site-centric solutions for a challenging antibiotic study",
"item": "https://www.fortrea.com/insights/creating-patient-and-site-centric-solutions-challenging-antibiotic-study"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/creating-patient-and-site-centric-solutions-challenging-antibiotic-study#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/creating-patient-and-site-centric-solutions-challenging-antibiotic-study#webpage"
},
"headline": "Antibiotic Clinical Trials Addressing Resistance with Patient- and Site-Centric Design | Fortrea Case Study",
"description": "Explore how this case study highlights the challenges in antibiotic clinical trials, including antibiotic resistance in emerging infectious diseases and barriers in global clinical development. Learn how patient- and site-centric strategies improve infectious disease patient recruitment, strengthen site engagement, and support more efficient trial execution. Explore how antibiotic clinical trial design must adapt to address evolving resistance patterns, operational complexity, and funding challenges in antibiotic development. Learn how site-focused collaboration and patient-centric approaches enhance study feasibility and outcomes in complex infectious disease trials. By integrating scientific innovation with patient- and site-centric execution, this case study demonstrates how antibiotic clinical trials can evolve to overcome challenges and advance infectious disease drug development.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2024-10/GettyImages-485488627.webp"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-14",
"dateModified": "2024-10-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-10/CS_0069_INFD_Challenge%20Antibiotic_0224_v1.pdf",
"encodingFormat": "application/pdf"
}
}
]
}